[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100346601":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":14,"centralContacts":19,"locations":28,"responsibleParty":52,"collaborators":7,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":7,"enrollmentInfo":64,"targetDuration":7,"studyType":67,"phases":7,"briefSummary":68,"conditions":69,"keywords":73,"overallStatus":31,"whyStopped":7,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Ludwig-Maximilians - University of Munich","OTHER",null,[9,12],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"EORTC QLQ C30","standardized questionaire",{"type":6,"name":13,"description":11,"armGroupLabels":7,"otherNames":7},"EORTC QLQ CR29",[15],{"name":16,"affiliation":17,"role":18},"Falk Roeder, MD","Ludwig-Maximilians Universität München","PRINCIPAL_INVESTIGATOR",[20,25],{"name":16,"role":21,"phone":22,"phoneExt":23,"email":24},"CONTACT","+49894400","73729","falk.roeder@t-online.de",{"name":26,"role":21,"phone":22,"phoneExt":23,"email":27},"Sabine Gerum, MD","sabine.gerum@med.uni-muenchen.de",[29],{"facility":30,"status":31,"city":32,"state":33,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Department of Radiation Oncology, University Hospital, LMU Munich","RECRUITING","Munich","Bavaria","81377","Germany","DE",{"type":38,"coordinates":39},"Point",[40,41],11.57549,48.13743,{"lat":41,"lon":40},[44,46,47,50],{"name":16,"role":21,"phone":22,"phoneExt":23,"email":45},"Falk.Roeder@med.uni-muenchen.de",{"name":26,"role":21,"phone":22,"phoneExt":23,"email":27},{"name":48,"role":49,"phone":7,"phoneExt":7,"email":7},"Franziska Walter, MD","SUB_INVESTIGATOR",{"name":51,"role":49,"phone":7,"phoneExt":7,"email":7},"Michael Hoffmann, MD",{"type":18,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Falk Roeder","Consultant","100346601","prospective-observational-trial-to-evaluate-quality-of-life-after-definitive-chemoradiation-in-patients-with-anal-cancer-lanacare-100346601",false,"NCT03792854","Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With Anal Cancer (LANACARE)","LANACARE","Inclusion Criteria:\n\n* histologically proven anal cancer without distant metastases\n* indication for definitive chemoradiation therapy based on multidisciplinary evaluation\n* age \\>=18 years\n* written informed consent\n* ability to answer the standardized questionaires according to the treating physician\n\nExclusion Criteria:\n\n* age \\\u003C 18 years\n* prior systemic therapy with regard to anal cancer\n* distant metastases\n* second malignancy","ALL","18 Years",{"count":65,"type":66},100,"ESTIMATED","OBSERVATIONAL","Observational study to evaluate longitudinal quality of life according to standardized EORTC questionaires as well as functional outcome, oncological outcome and toxicity in patients treated with definitive chemoradiation for anal cancer",[70,71,72],"Anal Cancer","Quality of Life","Chemoradiation",[74,75,76],"anal cancer","quality of life","chemoradiation","2019-01-02",{"date":79,"type":80},"2019-01-03","ACTUAL",{"date":82,"type":80},"2018-12-01",{"date":84,"type":66},"2026-12",{"name":5,"class":6},1]